These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15567923)

  • 21. Chronic allograft nephropathy in paediatric renal transplantation.
    Alexander SI; Fletcher JT; Nankivell B
    Pediatr Nephrol; 2007 Jan; 22(1):17-23. PubMed ID: 16944214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy.
    Shishido S; Asanuma H; Nakai H; Mori Y; Satoh H; Kamimaki I; Hataya H; Ikeda M; Honda M; Hasegawa A
    J Am Soc Nephrol; 2003 Apr; 14(4):1046-52. PubMed ID: 12660340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations.
    Chapman JR
    Kidney Int Suppl; 2005 Dec; (99):S108-12. PubMed ID: 16336561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy.
    Scholten EM; de Fijter JW; Paul LC
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Dec; 2(2):79-96. PubMed ID: 12769650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patients.
    Grinyo JM; Saval N; Campistol JM;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3750-5. PubMed ID: 21474575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome, insulin resistance, and chronic allograft dysfunction.
    Porrini E; Delgado P; Torres A
    Kidney Int Suppl; 2010 Dec; (119):S42-6. PubMed ID: 21116317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-immune interventions to protect kidney allografts in the long term.
    Cravedi P; Perico N; Remuzzi G
    Kidney Int Suppl; 2010 Dec; (119):S71-5. PubMed ID: 21116322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of chronic allograft nephropathy with vitamin D.
    Hullett DA; Laeseke PF; Malin G; Nessel R; Sollinger HW; Becker BN
    Transpl Int; 2005 Oct; 18(10):1175-86. PubMed ID: 16162105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of pregnancy on renal function after transplantation].
    Becquemont L; Thervet E; Legendre C; Landais P; Kreis H
    Presse Med; 1992 Dec; 21(41):1983-4. PubMed ID: 1294960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic allograft nephropathy.
    Colvin RB
    N Engl J Med; 2003 Dec; 349(24):2288-90. PubMed ID: 14668453
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal allograft pathology: crossing over to the new millennium.
    Gaber L; Solez K
    Pediatr Transplant; 1999 Nov; 3(4):249-51. PubMed ID: 10562968
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subclinical rejection, a condition of an emergent interest].
    Serón D; O'Valle F; Moreso F; García del Moral R
    Nefrologia; 2006; 26 Suppl 7():3-14. PubMed ID: 17763622
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-immunologic intervention in chronic allograft nephropathy.
    Arias M; Fernández-Fresnedo G; Rodrigo E; Ruiz JC; González-Cotorruelo J; Gómez-Alamillo C
    Kidney Int Suppl; 2005 Dec; (99):S118-23. PubMed ID: 16336564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bibliography. Current world literature. Renal medicine and renal transplantation.
    Curr Opin Urol; 2002 Mar; 12(2):165-83. PubMed ID: 18536130
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
    Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
    Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.